Influenza News

The FDA on Friday approved the first ever influenza vaccine that does not have to be given by a health care professional.

Presence of a fever and time since symptom onset were two factors that affected whether providers prescribed oseltamivir to infants with influenza, according to findings published in Journal of the Pediatric Infectious Diseases Society.

There are several methods and tools clinicians can utilize to improve vaccine confidence and boost immunization rates as the respiratory virus season approaches, according to an expert panel.

HHS announced that it will give Moderna around $176 million to accelerate the development of a messenger RNA-based pandemic influenza vaccine amid an ongoing outbreak of avian influenza.

We checked in with CDC Director Mandy K. Cohen, MD, MPH, for an update on the agency’s efforts to modernize the nation’s disease surveillance and data systems and improve how the CDC communicates with the public and physicians.

Participation in the Pediatric Academic Societies Meeting is back to pre-COVID-19 levels of engagement, according to one of the event’s program chairs.

Over the years, an old friend, Michael Cater, MD, a pediatrician at Children's Hospital of Orange County, California, has shared numerous interesting cases, some from exotic places during his time in the Army.

Moderna announced positive interim results from a phase 3 trial of its next-generation COVID-19 vaccine, which the company said will help pave the way for its combination shot against COVID-19 and influenza.

Personalized care could help patients and providers plan safe returns to work or school from respiratory illnesses, according to a research review.